Subscribe to the Voices in Health Care Value newsletter to be notified about new research, policies, and upcoming events relevant to the health care value community.
Welcome to the seventh issue of Voices in Health Care Value, the newsletter of the Research Consortium for Health Care Value Assessment (RC-HCVA). This issue features work from our colleagues at the Healthcare Value Hub. We appreciate your comments and inputs to subsequent issues. If you are interested in becoming a Colleague in Value (individuals and groups who work in this area or who are simply interested in its findings) please register here.
By George Miller
With funding from the Pharmaceutical Research and Manufacturers of America (PhRMA), the Research Consortium for Health Care Value Assessment (RC-HCVA) announces the initiation of a new grant program to fund innovative policy research to stimulate awareness for the need to broaden how value in health care is determined, evaluated, and can be increased and replicated across the U.S. The long-term program will fund projects that vary by topic and award size, engage both new and established researchers, employ quantitative and qualitative methods, and are both empirical and conceptual. However, the first round of awards will support invited researchers to conceptually explore issues related to health care value in the context of the COVID-19 pandemic. These initial awards will address topics such as the following:
Because of the timeliness of these topics, the first round of grants will be awarded quickly and will support development of relatively short research briefs to be completed by the end of August 2020. We anticipate that the briefs will be published as a series in a health policy journal. In addition, grantees will be asked to summarize their results in a webinar to be held in September. Watch this space for further information, including the specific topics to be addressed and their authors, links to the final products, and the opportunity to register for the webinar which will be open to the public.
In this issue of Voices in Health Care Value we highlight achievements in the sterling career of Dr. Michael Chernew. Dr. Chernew is the Leonard D. Schaeffer Professor of Health Care Policy and Director of the Healthcare Markets and Regulation Lab, Department of Health Care Policy at Harvard Medical School. He is co-founder of the V-BID Center at the University of Michigan and is a partner in VBID Health, which together with Altarum (with funding from the PhRMA Foundation), has created the Research Consortium for Health Care Value Assessment. On May 21, Dr. Chernew was named chair of the prestigious and influential Medicare Payment Advisory Commission (MedPAC). Prior to his Harvard appointment in 2006, he was on the faculty of the University of Michigan Department of Health Management and Policy, and the Department of Economics.
Dr. Chernew has been a thought-leader on health care economics for many years, contributing seminal work on important topics such as Value-Based Insurance Design; health care spending and utilization; alternative payment models; consumer-driven health care and shoppable services; and most recently national health expenditures in light of COVID-19. His work spans theoretical to policy-relevant analyses. A few of his recent articles are here:
Health Affairs – Transforming Medicare’s Payment Systems: Progress Shaped by the ACA
Health Affairs – Prices are Not “Reimbursements”
NEJM Catalyst Innovations in Care Delivery – How Different Payment Models Support (or Undermine) a Sustainable Health Care System: Rating the Underlying Incentives and Building a Better Model
The National Bureau of Economic Research – Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.
Health Affairs – What Do We Know About Prices and Hospital Quality?
Brookings Hamilton Project – A Proposal to Cap Provider Prices and Price Growth in the Commercial Health Care Market
These are a small sample of the thought-leading articles that Dr. Chernew has authored in his prolific career. We congratulate Dr. Chernew on his appointment as Chair of MedPAC and look forward to many more important contributions from him.
Sign up for Voices in Health Care Value
The Research Consortium for Health Care Value Assessment is a partnership between Altarum and VBID Health, with funding from the PhRMA Foundation as part of its Value Assessment Initiative, established to promote the pursuit of value in health care delivery in the U.S. Follow us at @ValueConsortium.